The Division of Hematology & Thromboembolism at McMaster University is internationally recognized for its excellence in research, education and patient care. Our members are derived not only from the Department of Medicine but also from Pathology & Molecular Medicine, as well as Oncology. We have close ties to our colleagues in the Department of Pediatrics’ Division of Pediatric Hematology/ Oncology. Several of our division members also hold cross-appointments in Health Research Methods, Evidence, and Impact.
The Division of Hematology & Thromboembolism at McMaster University provides clinical care for patients with hematological disorders at the four acute care sites in Hamilton. Members of the Division provide are also involved in leadership roles in the Hamilton Regional Laboratory Medicine Program (HRLMP).
Division members make important educational contributions at all levels, including clinical mentorship of medical students, internal medicine residents, residents from specialty programs, and clinical fellows; supervision at the Masters and Ph.D. level in Health Research Methods, Evidence and Impact; Biochemistry & Biomedical Sciences and Medical Education; and involvement in activities of the Royal College of Physicians and Surgeons of Canada. We have a highly respected Hematology Training Program and one of only three Adult Thrombosis Medicine Area of Focused Competence (AFC) Programs in Canada. Many of our faculty are involved in the Transfusion Medicine AFC Program, which is housed in the Department of Pathology and Molecular Medicine. All three programs underwent very successful Internal Reviews during the past year.
The Division has achieved world-wide recognition for its research in thrombosis and hemostasis, platelet physiology and function, blood transfusion therapy, the molecular biology of red cell disorders and clinical trials in malignant hematologic diseases. There are two research organizations, the Thrombosis and Atherosclerosis Research Institute (TaARI, directed by Dr. Jeffrey Weitz) and the McMaster Centre for Transfusion Research (directed by Dr. Donnie Arnold), devoted to hematology research. Many of our faculty are involved in the development of national and international clinical practice guidelines. Several faculty hold Endowed Chairs. Funding for our research comes from a variety of sources, including CIHR, the Heart and Stroke Foundation, Canadian Blood Services, and Hamilton Health Sciences. During the past year, division members were responsible for publications in leading journals, including New England Journal of Medicine, Lancet Hematology, Annals of Internal Medicine, JAMA, JAMA Internal Medicine, British Journal of Hematology, Circulation, Journal of the American College of Cardiology, and Blood. Three of our faculty, Dr. Jeffrey Weitz, Dr. John Eikelboom and Dr. Mark Crowther were included on the 2019 list of the world’s most-cited researchers.
The Division continues to recruit for both Research-Educators and Clinician-Educations who will contribute to and enhance our clinical, educational and research strengths. We look to utilize our local, national and international relationships to forward our research and educational missions. The benign and malignant hematology services across the city continue to work together and with local family physician groups to adopt standardized triage and referral pathways in order to effectively manage increasing service demands. Our Division has proven itself to be remarkably adaptable in the face of the COVID-19 pandemic with outpatient clinics and teaching sessions moving to virtual platforms in a short period of time and our researchers able to achieve funding success in special research competitions.